Podinour-XP 1.125 Injection
Marketer
Nourier Lab
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Podinour-XP 1.125 Injection
Injex-Pod 1.125 is a dual-action antibiotic injection used to combat a range of bacterial infections. Its mechanism inhibits microbial proliferation, thereby controlling infection spread. Administration must be strictly under medical guidance; missed doses should be avoided, and the prescribed treatment course completed regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek emergency care for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Prior to use, disclose all current medications to your physician. This is especially crucial for pregnant or lactating individuals. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration are essential for optimal recovery. Monitoring through laboratory tests may be employed to assess the medication's impact.
Uses of Podinour-XP 1.125 Injection
Infections caused by bacteria
Major Benefits of Podinour-XP 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Podinour-XP 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Podinour-XP 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Podinour-XP 1.125 Injection works:
Ceftriaxone and Tazobactum, the active components of Podinour-XP 1.125 Injection, work synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Podinour-XP 1.125 Injection.
PregnancySAFE IF PRESCRIBED
Injection of Podinour-XP 1.125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Podinour-XP 1.125 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Podinour-XP 1.125 Injection might reduce vigilance, impair visual acuity, and induce drowsiness or vertigo. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Podinour-XP 1.125 Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Caution is advised when administering Podinour-XP 1.125 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Dosage alterations for Podinour-XP 1.125 Injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Podinour-XP 1.125 Injection :
Omit a Podinour-XP 1.125 Injection dose? Seek medical advice immediately.
Facts to Know About Podinour-XP 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently